Hong Kong researchers discover compound that could help tackle MRSA

University of Hong Kong researchers identified a chemical compound that can help fight methicillin-resistant Staphylococcus aureus, without resorting to antibiotics, according to the South China Morning Post. The researcher published their findings in mBio.

The compound, NP16, inhibits the MRSA-produced staphyloxanthin, which can resist the human immune system. This allows the body to overcome MRSA and mitigate it.

For the study, researchers examined the effects of NP16 in infected mice. They found the use of MP16 caused MRSA bacteria levels to fall by a factor of 10 within a few days. Additionally, they found the compound was not toxic to human cells.

The researchers claim this is the first study to use chemical genetics to treat MRSA, and they are now looking to see if similar approaches could help fight other superbugs, such as drug-resistant E. coli, according to the report.

More articles on healthcare quality: 
Researchers develop diagnostic tool for Parkinson's detection 
5 things to know about clinical nurse specialists 
CDC activates Emergency Operations Center for Harvey response

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 


IC Database-3

Top 40 Articles from the Past 6 Months